
FDA Approves New Bladder Cancer Treatment Before Surgery
The FDA has approved a new bladder cancer treatment combining durvalumab and enfortumab vedotin, reducing recurrence risk by 49%.

New Treatment Cuts Death Risk in Advanced Lung Cancer
New treatment cuts death risk in advanced lung cancer by over 8 months, according to a phase 3 trial presented…

New obesity drug passes key heart safety test
Survodutide passes key heart safety test in phase 3 trial for high-risk obesity patients, marking first dual agonist cardiovascular outcomes…

New IL-17 inhibitors outperform others for scalp psoriasis treatment
New research shows IL-17 inhibitors like ixekizumab and brodalumab may offer one of the most effective short-term treatments for scalp…

AI speeds pancreatic cancer drug breakthrough amid access hurdles
AI speeds pancreatic cancer drug breakthrough with daraxonrasib, nearly doubling survival rates to 13.2 months in advanced cases.

Time-restricted eating may aid Type 1 diabetes control
Time-restricted eating may improve blood sugar control in Type 1 diabetes without added risks, a new clinical trial reveals.

Clinical trial boosts Perelel protein for women’s health
New clinical trial shows Perelel's Triple-Support Protein improves cholesterol, fullness, and memory in women's health. Learn the key results here.